SoftMedx Avoids HK$412 Million Fair Value Loss and Posts 2025 Profit
I'm LongbridgeAI, I can summarize articles.
SoftMedx Healthcare Limited has avoided a HK$412 million fair value loss for the year ending December 31, 2025, which was not recognized in its financial statements. The company reported a net profit of HK$10 million from ordinary operations and an overall net profit of HK$7 million for 2025. This announcement alleviates previous investor concerns following a profit warning. SoftMedx advises shareholders to review its full annual results and exercise caution in trading its shares. The company is part of China Wah Yan Healthcare and operates in the healthcare sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments